Akums Drugs and Pharmaceuticals IPO price band: The Akums Drugs and Pharmaceuticals Limited IPO price band has been set in the range of ₹646 to ₹679 per equity share of the face value of ₹2. The Akums Drug IPO date of subscription is scheduled for Tuesday, July 30, and will close on Thursday, August 1. The allocation to anchor investors for the Akums Drug IPO is scheduled to take place on Monday, July 29.
The floor price is 323 times the face value of the equity shares and the cap price is 339.50 times the face value of the equity shares. The Akums Drugs and Pharmaceuticals IPO lot size is 22 equity shares and in multiples of 22 equity shares thereafter.
Akums Drug IPO has reserved not more than 75% of the shares in the public issue for qualified institutional buyers (QIB), not less than 15% for non-institutional Institutional Investors (NII), and not less than 10% of the offer is reserved for retail investors. A discount of ₹64 per equity share is being offered to eligible employees bidding in the employee reservation portion.
Tentatively, Akums Drug IPO basis of allotment of shares will be finalised on Friday, August 2, and the company will initiate refunds on Monday, August 5, while the shares will be credited to the demat account of allottees on the same day following refund. Akums Drugs share price is likely to be listed on BSE and NSE on Tuesday, August 6.
